2021 annual financial data
Summit Therapeutics 2021 Net margin
Summit Therapeutics 2021 net margin with verified reported values.
Direct answer
Net margin was -4,762.13%.
Operating income was -86,186,000 GBP and net income was -86,147,000 GBP.
Operating cash flow was -53,807,000 GBP.
Get free Summit Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,809,000 GBP
- Operating income
- -86,186,000 GBP
- Net income
- -86,147,000 GBP
- Operating cash flow
- -53,807,000 GBP